• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非经典胰岛肽:胰腺及胰腺外作用

Nonclassical Islet Peptides: Pancreatic and Extrapancreatic Actions.

作者信息

English Andrew, Irwin Nigel

机构信息

School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, Northern Ireland, UK.

出版信息

Clin Med Insights Endocrinol Diabetes. 2019 Dec 12;12:1179551419888871. doi: 10.1177/1179551419888871. eCollection 2019.

DOI:10.1177/1179551419888871
PMID:32425629
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7216561/
Abstract

The pancreas has physiologically important endocrine and exocrine functions; secreting enzymes into the small intestine to aid digestion and releasing multiple peptide hormones via the islets of Langerhans to regulate glucose metabolism, respectively. Insulin and glucagon, in combination with ghrelin, pancreatic polypeptide and somatostatin, are the main classical islet peptides critical for the maintenance of blood glucose. However, pancreatic islets also synthesis numerous 'nonclassical' peptides that have recently been demonstrated to exert fundamental effects on overall islet function and metabolism. As such, insights into the physiological relevance of these nonclassical peptides have shown impact on glucose metabolism, insulin action, cell survival, weight loss, and energy expenditure. This review will focus on the role of individual nonclassical islet peptides to stimulate pancreatic islet secretions as well as regulate metabolism. In addition, the more recognised actions of these peptides on satiety and energy regulation will also be considered. Furthermore, recent advances in the field of peptide therapeutics and obesity-diabetes have focused on the benefits of simultaneously targeting several hormone receptor signalling cascades. The potential for nonclassical islet hormones within such combinational approaches will also be discussed.

摘要

胰腺具有重要的生理内分泌和外分泌功能;分别向小肠分泌酶以帮助消化,并通过胰岛释放多种肽类激素来调节葡萄糖代谢。胰岛素、胰高血糖素与胃饥饿素、胰多肽和生长抑素一起,是维持血糖水平至关重要的主要经典胰岛肽。然而,胰岛还合成许多“非经典”肽,最近已证明这些肽对整体胰岛功能和代谢具有重要作用。因此,对这些非经典肽生理相关性的深入了解已显示出对葡萄糖代谢、胰岛素作用、细胞存活、体重减轻和能量消耗的影响。本综述将重点关注单个非经典胰岛肽在刺激胰岛分泌以及调节代谢方面的作用。此外,还将考虑这些肽在饱腹感和能量调节方面更公认的作用。此外,肽疗法和肥胖 - 糖尿病领域的最新进展集中在同时靶向多个激素受体信号级联反应的益处上。还将讨论非经典胰岛激素在这种联合方法中的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7a8/7216561/110533b58808/10.1177_1179551419888871-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7a8/7216561/110533b58808/10.1177_1179551419888871-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7a8/7216561/110533b58808/10.1177_1179551419888871-fig1.jpg

相似文献

1
Nonclassical Islet Peptides: Pancreatic and Extrapancreatic Actions.非经典胰岛肽:胰腺及胰腺外作用
Clin Med Insights Endocrinol Diabetes. 2019 Dec 12;12:1179551419888871. doi: 10.1177/1179551419888871. eCollection 2019.
2
Classical and non-classical islet peptides in the control of β-cell function.经典和非经典胰岛肽在β细胞功能的调控作用。
Peptides. 2022 Apr;150:170715. doi: 10.1016/j.peptides.2021.170715. Epub 2021 Dec 24.
3
Role of islet peptides in beta cell regulation and type 2 diabetes therapy.胰岛肽在β细胞调节和 2 型糖尿病治疗中的作用。
Peptides. 2018 Feb;100:212-218. doi: 10.1016/j.peptides.2017.11.014.
4
Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas.胃饥饿素衍生肽影响胰岛素、胰高血糖素、胰多肽和生长抑素的分泌:对小鼠和大鼠胰腺分离胰岛的研究。
Regul Pept. 2008 Feb 7;146(1-3):230-7. doi: 10.1016/j.regpep.2007.09.017. Epub 2007 Sep 18.
5
Unraveling the role of the ghrelin gene peptides in the endocrine pancreas.解析胃饥饿素基因肽在内分泌胰腺中的作用。
J Mol Endocrinol. 2010 Sep;45(3):107-18. doi: 10.1677/JME-10-0019. Epub 2010 Jul 1.
6
Peptidergic regulation of maturation of the stimulus-secretion coupling in fetal islet beta cells.肽能对胎儿胰岛β细胞刺激-分泌偶联成熟的调节作用。
Pancreas. 2000 Apr;20(3):282-9. doi: 10.1097/00006676-200004000-00010.
7
Enteroinsular signaling: perspectives on the role of the gastrointestinal hormones glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide in normal and abnormal glucose metabolism.肠胰岛信号传导:关于胃肠激素胰高血糖素样肽1和葡萄糖依赖性促胰岛素多肽在正常和异常葡萄糖代谢中作用的观点
Curr Opin Clin Nutr Metab Care. 2003 Jul;6(4):461-8. doi: 10.1097/01.mco.0000078991.96795.84.
8
The novel roles of glucagon-like peptide-1, angiotensin II, and vitamin D in islet function.胰高血糖素样肽-1、血管紧张素 II 和维生素 D 在胰岛功能中的新作用。
Adv Exp Med Biol. 2010;654:339-61. doi: 10.1007/978-90-481-3271-3_15.
9
Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.调节胰岛应激轴作为糖尿病一种新的潜在治疗靶点。
Vitam Horm. 2014;95:195-222. doi: 10.1016/B978-0-12-800174-5.00008-9.
10
[Impact of islet alpha cell loss on insulin secretion].[胰岛α细胞丢失对胰岛素分泌的影响]
Zhonghua Yi Xue Za Zhi. 2002 Oct 25;82(20):1427-31.

引用本文的文献

1
Diagnostic Potential of Ratio Between Creatine Kinase and Amylase in Acute Pancreatitis.肌酸激酶与淀粉酶比值在急性胰腺炎中的诊断潜力
Mater Sociomed. 2023;35(4):280-284. doi: 10.5455/msm.2023.35.280-284.
2
Dietary Supplementation with Yerba Mate () Infusion Increases IRS-1 and PI3K mRNA Levels and Enhances Insulin Sensitivity and Secretion in Rat Pancreatic Islets.用马黛茶()冲泡液进行膳食补充可增加大鼠胰岛中胰岛素受体底物-1(IRS-1)和磷脂酰肌醇-3激酶(PI3K)的mRNA水平,并增强胰岛素敏感性和分泌。
Plants (Basel). 2023 Jul 12;12(14):2620. doi: 10.3390/plants12142620.
3
Noncanonical Regulation of cAMP-Dependent Insulin Secretion and Its Implications in Type 2 Diabetes.

本文引用的文献

1
Amylin Signaling in Diabetes and Alzheimer's Disease: Therapy or Pathology?糖尿病与阿尔茨海默病中的胰淀素信号传导:治疗手段还是病理因素?
J Neurol Neuromedicine. 2019;4(1):12-16. doi: 10.29245/2572.942X/2019/1.1212. Epub 2019 Feb 10.
2
Modified Peptide YY Molecule Attenuates the Activity of NPY/AgRP Neurons and Reduces Food Intake in Male Mice.修饰后的肽 YY 分子可减弱 NPY/AgRP 神经元的活性,减少雄性小鼠的食物摄入。
Endocrinology. 2019 Nov 1;160(11):2737-2747. doi: 10.1210/en.2019-00100.
3
Cholecystokinin (CCK) Regulation of Pancreatic Acinar Cells: Physiological Actions and Signal Transduction Mechanisms.
非规范调节环腺苷酸依赖的胰岛素分泌及其在 2 型糖尿病中的意义。
Compr Physiol. 2023 Jun 26;13(3):5023-5049. doi: 10.1002/cphy.c220031.
4
Sustained glucagon receptor antagonism in insulin-deficient high-fat-fed mice.胰岛素缺乏的高脂肪喂养小鼠中持续的胰高血糖素受体拮抗作用。
J Endocrinol. 2022 Sep 14;255(2):91-101. doi: 10.1530/JOE-22-0106. Print 2022 Nov 1.
5
A Practical Guide to Rodent Islet Isolation and Assessment Revisited.《啮齿动物胰岛分离与评估实用指南(再版)》
Biol Proced Online. 2021 Mar 1;23(1):7. doi: 10.1186/s12575-021-00143-x.
胆囊收缩素(CCK)对胰腺腺泡细胞的调节:生理作用和信号转导机制。
Compr Physiol. 2019 Mar 14;9(2):535-564. doi: 10.1002/cphy.c180014.
4
in Obesity and Cardiometabolic Diseases: A Systematic Review.在肥胖与心血管代谢疾病:系统综述。
J Am Coll Nutr. 2019 Jul;38(5):478-484. doi: 10.1080/07315724.2018.1553116. Epub 2019 Mar 12.
5
Vasopressin receptors in islets enhance glucose tolerance, pancreatic beta-cell secretory function, proliferation and survival.胰岛中的血管升压素受体可增强葡萄糖耐量、胰岛β细胞的分泌功能、增殖和存活。
Biochimie. 2019 Mar;158:191-198. doi: 10.1016/j.biochi.2019.01.008. Epub 2019 Jan 21.
6
Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMP.在用于 cAMP 的高通量 FRET 测定中发现,非传统胰高血糖素和 GLP-1 受体激动剂和拮抗剂在 GLP-1 受体上相互作用。
J Biol Chem. 2019 Mar 8;294(10):3514-3531. doi: 10.1074/jbc.RA118.005682. Epub 2019 Jan 8.
7
Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer's disease.三重GLP-1/GIP/胰高血糖素受体激动剂,一种治疗阿尔茨海默病的潜在新策略。
Expert Opin Investig Drugs. 2019 Jan;28(1):93-97. doi: 10.1080/13543784.2019.1552677. Epub 2018 Dec 1.
8
LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept.LY3298176,一种新型双重 GIP 和 GLP-1 受体激动剂,用于治疗 2 型糖尿病:从发现到临床概念验证。
Mol Metab. 2018 Dec;18:3-14. doi: 10.1016/j.molmet.2018.09.009. Epub 2018 Oct 3.
9
Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.LY3298176,一种新型双重 GIP 和 GLP-1 受体激动剂,在 2 型糖尿病患者中的疗效和安全性:一项随机、安慰剂对照和阳性对照药物对照的 2 期临床试验。
Lancet. 2018 Nov 17;392(10160):2180-2193. doi: 10.1016/S0140-6736(18)32260-8. Epub 2018 Oct 4.
10
Peptide-based multi-agonists: a new paradigm in metabolic pharmacology.基于肽的多激动剂:代谢药理学的新范例。
J Intern Med. 2018 Dec;284(6):581-602. doi: 10.1111/joim.12837. Epub 2018 Oct 23.